The fate of the large striatal interneurons expressing calretinin in Huntington's disease

Neuroscience Research

Volumn 62, Issue 4, 2008, Pages 216-224

  Massouh, Mireille ^a   Wallman, Marie Josée ^a   Pourcher, Emmanuelle ^a,b   Parent, André ^a  

^a CENTRE DE RECHERCHE DE L INSTITUT UNIVERSITAIRE EN SANTÉ MENTALE DE QUÉBEC   (Canada)

^b Quebec Memory and Motor Skills Disorders Research Center   (Canada)

Author keywords

Basal ganglia; Cholinergic interneurons; Human brain; Neurodegenerative diseases; Striatum

Indexed keywords

CALRETININ; CHOLINE ACETYLTRANSFERASE; CHROMIUM; NEUROKININ 1 RECEPTOR;

ARTICLE; CELL DENSITY; CELL STRUCTURE; CELLULAR DISTRIBUTION; HUMAN; HUNTINGTON CHOREA; INTERNEURON; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL COUNT; CHOLINE O-ACETYLTRANSFERASE; CORPUS STRIATUM; FEMALE; HUMANS; HUNTINGTON DISEASE; INTERNEURONS; MALE; MIDDLE AGED; RECEPTORS, NEUROKININ-1;

EID: 55849096212     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2008.08.007     Document Type: Article

References (31)

1. Aubry J.M., Lundstrom K., Kawashima E., Ayala G., Schulz P., Bartanusz V., and Kiss J.Z. NK1 receptor expression by cholinergic interneurones in human striatum. Neuroreport 5 (1994) 1597-1600
2. Cicchetti F., and Parent A. Striatal interneurons in Huntington's disease: selective increase in the density of calretinin-immunoreactive medium-sized neurons. Mov. Disord. 11 (1996) 619-626
3. Cicchetti F., Gould P.V., and Parent A. Sparing of striatal neurons coexpressing calretinin and substance P (NK1) receptor in Huntington's disease. Brain Res. 730 (1996) 232-237
4. Cicchetti F., Beach T.G., and Parent A. Chemical phenotype of calretinin interneurons in the human striatum. Synapse 30 (1998) 284-297
5. Cicchetti F., Prensa L., Wu Y., and Parent A. Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington's disease. Brain Res. Rev. 34 (2000) 80-101
6. DeArmond S.J., Fusco M.M., and Dewey M.M. Structure of the Human Brain (1976), Oxford University Press, New York
7. Deng Y.P., Albin R.L., Penney J.B., Young A.B., Anderson K.D., and Reiner A. Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study. J. Chem. Neuroanat. 27 (2004) 143-164
8. DiFiglia M., Pasik P., and Pasik T. A Golgi study of neuronal types in the neostriataum of monkeys. Brain Res. 114 (1976) 245-256
9. Eckenstein F., and Sofroniew M.V. Identification of central cholinergic neurons containing both choline acetyltransferase and acetylcholinesterase and of central neurons containing only acetylcholinesterase. J. Neurosci. 3 (1983) 2286-2291
10. Ferrante R.J., Kowall N.W., Beal M.F., Martin J.B., Bird E.D., and Richardson Jr. E.P. Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J. Neuropathol. Exp. Neurol. 46 (1987) 12-27
11. Ferrer I., Kulisevsky J., Gonzalez G., Escartin A., Chvite A., and Casas R. Parvalbumin-immunoreactive neurons in the cerebral cortex and striatum in Huntington's disease. Neurodegenaration 3 (1994) 169-173
12. Harrington K.M., and Kowall N.W. Parvalbumin immunoreactive neurons resist degeneration in Huntington's disease striatum. J. Neuropathol. Exp. Neurol. 50 (1991) 309
13. Izzo P.N., and Bolam J.P. Cholinergic synaptic input to different parts of spiny striatonigral neurons in the rat. J. Comp. Neurol. 269 (1988) 219-234
14. Kanazawa I., Sasaki H., Muramoto O., Matsushita M., Mizutani T., Iwabuchi K., Ikeda T., and Takahata N. Studies on neurotransmitter markers and striatal neuronal cell density in Huntington's disease and dentatorubropallidoluysian atrophy. J. Neurol. Sci. 70 (1985) 151-165
15. Kowall N.W., Ferrante R.J., and Martin J.B. Patterns of cell loss in Huntington's disease. Trends Neurosci. 10 (1987) 24-29
16. Kowall N.W., Quigley Jr. B.J., Krause J.E., Lu F., Kosofsky B.E., and Ferrante R.J. Substance P and substance P receptor histochemistry in human neurodegenerative diseases. Regul. Peptides 46 (1993) 174-185
17. Kuramoto E., Fujiyama F., Unzai T., Nakamura K., Hioki H., Furuta T., Shigemoto R., Ferraguti F., and Kaneko T. Metabotropic glutamate receptor 4-immunopositive terminals of medium-sized spiny neurons selectively form synapses with cholinergic interneurons in the rat neostriatum. J. Comp. Neurol. 500 (2007) 908-922
18. Levesque M., Parent R., and Parent A. Cellular and subcellular localization of neurokinin-1 and neurokinin-3 receptors in primate globus pallidus. Eur. J. Neurosci. 23 (2006) 2760-2772
19. Li J.L., Kaneko T., and Mizuno N. Colocalization of neuronal nitric oxide synthase and neurokinin-1 receptor in striatal interneurons in the rat. Neurosci. Lett. 310 (2001) 109-112
20. McGeer P.L., McGeer E.G., and Fibiger H.C. Choline acetylase and glutamic acid decarboxylase in Huntington's chorea. A preliminary study. Neurology 23 (1973) 912-917
21. Mounir S., and Parent A. The expression of neurokinin-1 receptor at striatal and pallidal levels in normal human brain. Neurosci. Res. 44 (2002) 71-81
22. Parent A., and Hazrati L.N. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Rev. 20 (1995) 91-127
23. Parent A., Cicchetti F., and Beach T.G. Calretinin-immunoreactive neurons in the human striatum. Brain Res. 674 (1995) 347-351
24. Parent A., Cicchetti F., and Beach T.G. Striatal neurones displaying substance P (NK1) receptor immunoreactivity in human and non-human primates. Neuroreport 6 (1995) 721-724
25. Prensa L., Gimenez-Amaya J.M., and Parent A. Morphological features of neurons containing calcium-binding proteins in the human striatum. J. Comp. Neurol. 390 (1998) 552-563
26. Sidibe M., and Smith Y. Thalamic input to striatal interneurons in monkeys: synaptic organization and co-localization of calcium-binding proteins. Neuroscience 89 (1999) 1189-1208
27. Smith Y., Bevan M.D., Shink E., and Bolam J.P. Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 86 (1998) 353-387
28. Smith R., Chung H., Rundquist S., Maat-Schieman M.L., Colgan L., Englund E., Liu Y.J., Roos R.A., Faull R.L., Brundin P., and Li J.Y. Cholinergic neuronal defect without cell loss in Huntington's disease. Hum. Mol. Genet. 15 (2006) 3119-3131
29. Storey E., and Beal M.F. Neurochemical substrates of rigidity and chorea in Huntington's disease. Brain 116 (1993) 1201-1222
30. Suzuki M., Desmond T.J., Albin R.L., and Frey K.A. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers. Synapse 41 (2001) 329-336
31. Wu Y., and Parent A. Striatal interneurons expressing calretinin, parvalbumin or NADPH-diaphorase: a comparative study in the rat, monkey and human. Brain Res. 863 (2000) 182-191